We are live on
!
Find out more
Aptevo Therapeutics
APVO
APVO
hedge funds and large institutions have $18M invested in Aptevo Therapeutics in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
32% less capital invested
Capital invested by funds: $26.5M → $18M (-$8.45M)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GP
GLG Partners
London,
United Kingdom
|
-$873K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$241K |
| 3 |
SIM
Strategic Investment Management
Arlington,
Virginia
|
-$106K |
| 4 |
Renaissance Technologies
New York
|
-$47K |
| 5 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
-$41K |
